Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery
Abstract
As a non-invasive method of local and systemic drug delivery, the administration of active pharmaceutical ingredients (APIs) via the pulmonary route represents an ideal approach for the therapeutic treatment of pulmonary diseases. The pulmonary route provides a number of advantages, including the rapid absorption which results from a high level of vascularisation over a large surface area and the successful avoidance of first-pass metabolism....
Paper Details
Title
Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery
Published Date
Aug 29, 2021
Journal
Volume
30
Issue
3
Pages
233 - 243
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History